Journal of Heart and Lung Transplantation

Papers
(The H4-Index of Journal of Heart and Lung Transplantation is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation377
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report — 2021; Focus on recipient charact273
A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors176
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report — 2021; Focus on recipient charac159
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients159
Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion130
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry129
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response113
Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients106
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry83
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience79
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update69
Mortality in patients with cardiogenic shock supported with VA ECMO: A systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients60
Heart transplantation following donation after circulatory death: Expanding the donor pool58
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients54
Berlin Heart EXCOR and ACTION post-approval surveillance study report53
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-ninth adult lung transplantation report—2022; focus on lung transplant reci52
International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation51
The impact of frailty on mortality after heart transplantation51
Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT47
COVID-19 vaccination in our transplant recipients: The time is now47
Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study47
ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association47
Donor heart selection: Evidence-based guidelines for providers46
Systemic ventricular assist device support in Fontan patients: A report by ACTION43
Increased early acute cellular rejection events in hepatitis C-positive heart transplantation41
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric heart transplantation report — 2021; focus on recipient ch41
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension40
Improved survival after heart transplantation in patients bridged with extracorporeal membrane oxygenation in the new allocation system40
Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment39
Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes38
Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support37
Mitochondrial transplantation for myocardial protection in ex-situ‒perfused hearts donated after circulatory death37
First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany37
Pregnancy in pulmonary arterial hypertension: Midterm outcomes of mothers and offspring36
The results of a single-center experience with HeartMate 3 in a biventricular configuration36
The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report—2022; focus on transplant for rest36
Cell death and ischemia-reperfusion injury in lung transplantation36
Right ventricular function and cardiopulmonary performance among patients with heart failure supported by durable mechanical circulatory support devices36
0.052972078323364